Not blinding sampling times [Bioanalytics]

posted by Obinoscopy  – USA, 2018-08-20 00:20 (2243 d 22:06 ago) – Posting: # 19177
Views: 3,957

Hi Helmut,

❝ Even if substantial carry-over is not apparent in method validation (which would call for injecting mobile phase between samples), it exists. The EMA’s GL tells us [...]



Going by that guideline, will it be safe to say that the converse it also true. That is:

If it appears there is no carry-over, study samples should be randomised


Well, just as you said, carryover is always very likely. Thus complete randomisation will not be the reasonable path to follow.

Thanks guys, at least I am glad I let my thoughts out and not get drowned in them.
—
Scopy

Complete thread:

UA Flag
Activity
 Admin contact
23,249 posts in 4,885 threads, 1,652 registered users;
87 visitors (0 registered, 87 guests [including 10 identified bots]).
Forum time: 22:27 CEST (Europe/Vienna)

The rise of biometry in this 20th century,
like that of geometry in the 3rd century before Christ,
seems to mark out one of the great ages or critical periods
in the advance of the human understanding.    R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5